Table 1. Baseline characteristics.
| Bimatoprost 0.03% | Bimatoprost 0.01% | P-value | |
|---|---|---|---|
| Global clinical score (n±SD) | 4.4±3.2 | 4.7±3.8 | 0.911 |
| Conjunctival hyperemia (n±SD) | 1.9±1.6 | 2.1±1.9 | 0.709 |
| Meniscus tear (n±SD) | 0.2±0.0 | 0.2±0.0 | 0.905 |
| Schirmer's test (s±SD) | 10.1±5.0 | 9.8±5.5 | 0.593 |
| Break-up time (s±SD) | 9.8±4.7 | 9.3±5.3 | 0.593 |
| Corneal epithelium density (n±SD) | 7430.8±2155.0 | 7775.9±2621.9 | 0.469 |
| Corneal endothelium density (n±SD) | 2917.0±956.1 | 2913.9±979.2 | 0.976 |
| Conjunctival epithelium density (n±SD) | 4266.8±1656.0 | 4357.9±1618 | 0.813 |
| Goblet cell density (n±SD) | 353.9±179.6 | 351.8±192.3 | 0.894 |
| IOP (mm Hg±SD) | 14.30±2.00 | 14.13±1.68 | 0.687 |